These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6308330)

  • 1. Serological status of cytomegalovirus and outcome of renal transplantation.
    Niaudet P; Raguin G; Lefevre JJ; Busson M; Cabau N; Fortier B; Boue A; Broyer M; Bedrossian J; Fries D; Kreis H; Sraer JD
    Kidney Int Suppl; 1983 May; (14):S-50-3. PubMed ID: 6308330
    [No Abstract]   [Full Text] [Related]  

  • 2. Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients.
    Rook AH; Smith WJ; Burdick JF; Manischewitz JF; Frederick W; Siegel JP; Williams GM; Quinnan GV
    Transplant Proc; 1984 Dec; 16(6):1466-9. PubMed ID: 6095498
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytomegalovirus infection and kidney graft survival.
    Spencer ES; Fjeldborg O; Andersen HK
    Scand J Urol Nephrol Suppl; 1981; 64():128-31. PubMed ID: 6293049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cytomegalovirus antibody status on graft survival in renal transplantation.
    Fauchald P; Leivestad T; Rollag H; Albrechtsen D; Sødal G
    Transplant Proc; 1994 Jun; 26(3):1725. PubMed ID: 8030103
    [No Abstract]   [Full Text] [Related]  

  • 5. The importance of cytotoxic cellular immunity in the protection from cytomegalovirus infection.
    Quinnan GV; Rook AH
    Birth Defects Orig Artic Ser; 1984; 20(1):245-61. PubMed ID: 6329365
    [No Abstract]   [Full Text] [Related]  

  • 6. A prospective study of cytomegalovirus infections in 78 renal allograft recipients.
    Braun WE; Nankervis G; Banowsky LH; Protiva D; Biekert E; McHenry MC
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():8-12. PubMed ID: 197584
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-immunologic problems in kidney transplantation].
    Lanzer G
    Wien Med Wochenschr; 1981; 131(6):139-43. PubMed ID: 6455015
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological analysis of cytomegalovirus reactivation in renal transplant patients.
    Sakamaki T; Omori K; Kashiwabara H; Hachisu T; Nakazawa R; Tsuchida H; Yokoyama T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2075-6. PubMed ID: 2540556
    [No Abstract]   [Full Text] [Related]  

  • 9. Better allograft survival in erythrocyte type-O recipients correlates with resistance to cytomegalovirus infections.
    Andrus CH; Betts RF; May AG; Freeman RB
    Transplant Proc; 1981 Mar; 13(1 Pt 1):120-4. PubMed ID: 6267749
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of cytomegalovirus infection and HLA-matching on outcome of renal transplantation.
    Waltzer WC; Arnold AN; Anaise D; Hurley S; Raisbeck A; Egelandsdsdal B; Pullis C; Rapaport FT
    Transplant Proc; 1987 Oct; 19(5):4077-80. PubMed ID: 2823434
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction between cytomegalovirus infection and renal transplant rejection.
    Tourkantonis A; Lazaridis A
    Kidney Int Suppl; 1983 May; (14):S-46-9. PubMed ID: 6308329
    [No Abstract]   [Full Text] [Related]  

  • 12. [Circulating immunocomplexes in patients after kidney transplantation in relation to infection and rejection].
    Matl I; Hasková V; Kaslík J; Kocandrle V; Seeman J
    Cas Lek Cesk; 1983 Feb; 122(7):196-9. PubMed ID: 6299568
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of presence of HBs antigen and anti-hepatitis C virus and anti-cytomegalovirus antibodies on transplanted kidney survival.
    Sieńko J; Wiśniewska M; Ciechanowski K; Rózański J; Domański L; Myslak M; Kamiński M; Sulikowski T; Pabisiak K; Romanowski M; Mizerski A; Tejchman K; Nowacki M; Ostrowski M; Bohatyrewicz R
    Transplant Proc; 2006; 38(1):136-8. PubMed ID: 16504685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between antibody response against cytomegalovirus strain-specific glycoprotein H epitopes and HLA-DR.
    Ishibashi K; Tokumoto T; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Shishido K; Aikawa K; Yamaguchi O; Toma H; Tanabe K; Suzutani T
    Microbiol Immunol; 2009 Jul; 53(7):412-6. PubMed ID: 19563400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplant survival and antibody to hepatitis virus.
    Cuthbert J; Ware A; Combes B; Mauk R; Hull A
    N Engl J Med; 1977 Nov; 297(19):1068. PubMed ID: 333289
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of immune responsiveness to cytomegalovirus infection with survival of renal allografts.
    Chatterjee S; Cosgrove D; Azen S; Fiala M
    J Urol; 1980 Oct; 124(4):448-50. PubMed ID: 6252355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of epidemiology and treatment factors to infection and allograft survival in renal transplantation.
    Betts RF
    Birth Defects Orig Artic Ser; 1984; 20(1):87-99. PubMed ID: 6329375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.